ALNY

NASDAQStock

Alnylam Pharmaceuticals, Inc.

$313.45-3.77 (-1.19%)

52-Week Range

$224.32
$491.22

Key Stats

Market Cap

41.6B

P/E Ratio

155.95

Dividend Yield

Beta

0.38

Volume

526.0K

Avg Volume

1.5M

Performance

1M

+2.84%

3M

-18.97%

6M

-31.21%

YTD

-20.73%

1Y

+31.22%

3Y

+70.78%

5Y

+117.10%

Price Chart

ETF Exposure

ALNY is held by 460 ETFs

ETFFund NameWeight
SUAS.LiShares MSCI USA SRI UCITS ETF0.32%
SUUS.LiShares MSCI USA SRI UCITS ETF0.32%
JDOCJPMorgan Healthcare Leaders ETF0.32%
REMCColumbia Research Enhanced Mid Cap ETF0.32%
HEQQJPMorgan Nasdaq Hedged Equity Laddered Overlay ETF0.32%
IWRiShares Russell Mid-Cap ETF0.32%
USMViShares MSCI USA Min Vol Factor ETF0.32%
XMVU.SGXtrackers MSCI USA Minimum Volatility UCITS ETF 1D0.32%
XMU.TOiShares MSCI Min Vol USA Index ETF0.32%
GTPEGoldman Sachs MSCI World Private Equity Return Tracker ETF0.30%
IMCBiShares Morningstar Mid-Cap ETF0.30%
JKGiShares Morningstar Mid-Cap ETF0.30%
HQGOHartford US Quality Growth ETF0.29%
XFVT.LXtrackers Vietnam Swap UCITS ETF 1C0.29%
QGRWWisdomTree U.S. Quality Growth Fund0.29%
FTXHFirst Trust Nasdaq Pharmaceuticals ETF0.28%
VFMOVanguard U.S. Momentum Factor ETF0.28%
JEPQJPMorgan Nasdaq Equity Premium Income ETF0.27%
PTNQPacer Trendpilot 100 ETF0.26%
ROUSHartford Multifactor US Equity ETF0.26%
MODLVictoryShares WestEnd U.S. Sector ETF0.25%
XMUD.LXtrackers MSCI USA Swap UCITS ETF 1C0.25%
XMUS.LXtrackers MSCI USA Swap UCITS ETF 1C0.25%
CGGOCapital Group Global Growth Equity ETF0.25%
JMOMJPMorgan U.S. Momentum Factor ETF0.25%
500.PAAmundi S&P 500 Swap UCITS ETF EUR Acc0.24%
XTiShares Future Exponential Technologies ETF0.24%
CLSEConvergence Long/Short Equity ETF0.24%
QCLRGlobal X - Nasdaq 100 Collar 95-110 ETF0.24%
NULCNuveen ESG Large-Cap0.23%
QTRGlobal X - Nasdaq 100 Tail Risk ETF0.23%
QRMIGlobal X - Nasdaq 100 Risk Managed Income ETF0.23%
QYLGGlobal X - Nasdaq 100 Covered Call & Growth ETF0.23%
QDVC.DEiShares MSCI USA Mid-Cap Equal Weight UCITS ETF0.23%
CNDX.LiShares NASDAQ 100 UCITS ETF0.23%
CNX1.LiShares NASDAQ 100 UCITS ETF0.23%
CSNDX.SWiShares NASDAQ 100 UCITS ETF0.23%
GPIQGoldman Sachs Nasdaq-100 Premium Income ETF0.23%
SXRV.DEiShares NASDAQ 100 UCITS ETF0.23%
EQQD.LInvesco NASDAQ-100 Swap UCITS ETF0.23%
EQQS.LInvesco NASDAQ-100 Swap UCITS ETF0.23%
QQQInvesco QQQ Trust, Series 10.23%
QQQMInvesco NASDAQ 100 ETF0.23%
XNAS.FXtrackers NASDAQ 100 UCITS ETF 1C0.23%
XNAS.LXtrackers NASDAQ 100 UCITS ETF 1C0.23%
EQEU.DEInvesco EQQQ NASDAQ-100 UCITS ETF (EUR Hdg)0.23%
EQGB.SWInvesco EQQQ Nasdaq-100 UCITS ETF0.23%
EQQQ.DEInvesco EQQQ Nasdaq-100 UCITS ETF0.23%
EQQQ.LInvesco EQQQ Nasdaq-100 UCITS ETF0.23%
EQQU.LInvesco EQQQ Nasdaq-100 UCITS ETF0.23%
PreviousPage 3 of 10Next

About ALNY ETF Exposure

Alnylam Pharmaceuticals, Inc. (ALNY) is held by 460 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 41.6B, ALNY is a widely held institutional stock. The stock currently trades at $313.45. Investors can gain exposure to ALNY through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ALNY, sorted by portfolio weight.